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Over the last few years, numerous studies solidified the hypothesis that fibroblast growth 
factor (FGF) signaling regulates neuroendocrine progenitor cell proliferation, fate spec-
ification, and cell survival and, therefore, is critical for the regulation and maintenance 
of homeostasis of the body. One important example that underscores the involvement 
of FGF signaling during neuroendocrine cell development is gonadotropin-releasing 
hormone (GnRH) neuron ontogenesis. Indeed, transgenic mice with reduced olfactory 
placode (OP) Fgf8 expression do not have GnRH neurons. This observation indicates 
the requirement of FGF8 signaling for the emergence of the GnRH neuronal system in 
the embryonic OP, the putative birth place of GnRH neurons. Mammalian reproductive 
success depends on the presence of GnRH neurons to stimulate gonadotropin secretion 
from the anterior pituitary, which activates gonadal steroidogenesis and gametogenesis. 
Together, these observations are critical for understanding the function of GnRH neurons 
and their control of the hypothalamus–pituitary–gonadal (HPG) axis to maintain fertility. 
Taken together, these studies illustrate that GnRH neuron emergence and hence HPG 
function is vulnerable to genomic and molecular signals that abnormally modify Fgf8 
expression in the developing mouse OP. In this short review, we focus on research that 
is aimed at unraveling how androgen, all-trans retinoic acid, and how epigenetic factors 
modify control mouse OP Fgf8 transcription in the context of GnRH neuronal develop-
ment and mammalian reproductive success.
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inTRODUCTiOn
Fibroblast growth factor (FGF) 8 (FGF8) signaling regulates neuroendocrine progenitor cell prolif-
eration, fate specification, and cell survival and has therefore been hypothesized to be critical for the 
development and maintenance of homeostatic systems in the body such as the hypothalamus–pitui-
tary–axis (HPG) (1–5). Indeed, FGF8 has been shown to be critical for emergence of gonadotropin-
releasing hormone (GnRH) neurons (1, 2, 6). Later studies also demonstrated that FGF8 affects 
the postnatal maturation of vasopressin, oxytocin, kisspeptin, and corticotropin-releasing hormone 
neurons found in the mammalian hypothalamus (1, 2, 4, 6–8).
FiGURe 1 | Proposed mechanism for coordinate regulation of 
transient Fgf8 transcription in the mouse OP. Sagittal schematic 
representation of the ~E8.5–E11.5 mouse nasal region. FGF8 expressing 
cells located in the respiratory epithelium (blue region) are required for GnRH 
neuron emergence in the embryonic mouse mOP (red circles) located in the 
olfactory epithelium (gray region). Evidence from our and other studies 
indicates three major signaling mechanisms that regulate transient Fgf8 
expression in the embryonic mouse OP. First, our data showed that AR 
directly interacts with its ARE sites on the Fgf8 promoter region. However, in 
contrast to our premise, DHT did not upregulate Fgf8 expression in GT1–7 
neurons or the embryonic OP. Second, inhibition of DNMT activity 
upregulated Fgf8 expression suggesting that the erasure of DNA methylation 
induced Fgf8 promoter activity. Surprisingly, DHT was able to block this 
effect, which led us to infer that androgen signaling-dependent modulation of 
Fgf8 transcription in the embryonic OP is reliant on the epigenetic status of 
the Fgf8 promoter. Third, ATRA signaling clearly inhibits Fgf8 expression. The 
embryonic OP exhibits an age-dependent increase in ATRA levels due to the 
local upregulation of Raldh3 expression [converts vitamin (Vit) A to ATRA] in 
the dorsal–caudal region olfactory epithelium (green region), which then acts 
through RARs to inhibit Fgf8 expression. These data led us to update our 
hypothesis as to how transient Fgf8 transcription is controlled in the 
embryonic mouse OP: upregulation of Fgf8 transcriptional activity is DNA 
methylation-dependent, which is subsequently downregulated through 
androgen and/or ATRA signaling. In this context, androgen and/or ATRA 
signaling may act as a transcriptional brake to limit FGF8’s morphogenetic or 
proliferative effects on the embryonic mouse OP. NE, neurepithelium.
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In humans, Fgf8 point mutations cause Kallmann syndrome 
(KS), a form of congenital hypogonadotropic hypogonadism 
(HH) that is associated with anosmia (6, 9). Generally, KS 
patients do not undergo puberty and are infertile in adulthood. 
These observations indicate that embryonic disruptions in FGF8 
signaling can abrogate GnRH neuronal development and hence 
cause infertility. Genetic screenings of individuals with GnRH 
deficiencies identified that Fgf8 is not the only gene that is impor-
tant for GnRH (progenitor) cell development, fate specification, 
and migration (3, 5, 10, 11). Indeed, KS patients can also harbor 
mutations in anosmin-1 (12–14), fibroblast growth factor recep-
tor-1 (Fgfr1) (15), prokineticin 2 (16) and its receptor (17), and 
chromodomain helicase-DNA-binding 7 (18). In this short review, 
we limit our discussion to the role of FGF8 signaling during 
GnRH neuron emergence and how Fgf8 transcriptional activity 
may be controlled during olfactory placode (OP) development.
The majority of the evidence indicating that FGF8 function 
is required for the emergence and possibly function of GnRH 
neurons is derived from studies investigating how FGF8 signaling 
controls the emergence of the GnRH neuronal system in humans 
and mice (2, 3, 5, 6, 11, 19–21). FGF8 is a member of the large 
FGF signaling family (22) that can act through four membrane-
bound tyrosine kinase FGF receptors (FGFRs) in humans and 
mice (23–26). Stable binding of FGFs in the presence of heparin 
proteoglycans enables FGFR dimerization and initiates a myriad 
of intracellular signal transduction pathways (27). The inherent 
complexity of the FGF signaling system and their functional 
redundancy demonstrates the robustness of FGF signaling dur-
ing embryonic development (28).
Two landmark studies published in the late 1980s have been 
essential in understanding where and when FGF8 signaling is 
critical during the development of the GnRH neuronal system 
(29, 30). Indeed, these studies presented convincing evidence that 
hypothalamic GnRH neurons in rodents and humans are born 
specifically in the medial OP (mOP) (Figure  1). A surprising 
finding, which meant that the OP morphogenetic region, which 
was generally known to be the anatomical precursor of the fron-
tonasal facial structures (29, 30), also gave rise to a very specific 
and important hypothalamic neuroendocrine cell population.
Proliferation studies indicate that GnRH progenitor cells 
become postmitotic around embryonic day (E) 9.5 (30, 31). 
Following their emergence from the mOP, GnRH neurons 
migrate along the nasal septum, all the while following the olfac-
tory, vomeronasal, and terminal nerves to the preoptic area and 
hypothalamus (2, 10, 30, 31). Postnatally, the majority of GnRH 
neurons are localized around the anterior tip of the third ventricle 
called organum vasculosum lamina terminalis in the preoptic 
area and project their axons to the external zone of the median 
eminence. Upon stimulation, they release the GnRH decapeptide 
into the portal vein system to activate gonadotropin release and 
production from gonadotrophs in the anterior pituitary into the 
systemic circulation, ultimately stimulating gonadal steroidogen-
esis and gametogenesis (3, 5). In the following sections, we will 
describe what is known about the emergence of GnRH neurons in 
the mOP, the role of FGF8 signaling, and how FGF8 transcription 
may be controlled during the mid-gestational development of the 
mouse OP.
OnTOGenesis OF THe GnRH neUROnal 
sysTeM
Two independent studies found that GnRH expressing neurons 
emerge from the mOP (30, 31). Interestingly, proliferation studies 
indicated that the vast majority (~80%) of mouse GnRH neurons 
become postmitotic in the mOP between E9.5 and E10.5 (29), 
which not only indicates that the birth place of GnRH progenitor 
cells is very likely localized in the embryonic mOP but also that 
GnRH-neuron fate specification occurs prior to E9.5.
The OP is an ectodermal region that gives rise to (non-sensory) 
respiratory epithelium and (sensory) olfactory epithelium (32–34). 
The olfactory epithelium develops into the main olfactory and 
vomeronasal systems (35, 36). Ablation studies support that the 
mOP is the birthplace of GnRH neurons. For example, amphibians 
that undergo OP removal ultimately lack the olfactory epithelium, 
nerve, and bulb, as well as GnRH neurons of the forebrain (37, 
38). On the other hand, chick studies indicate that GnRH neurons 
emerge from the respiratory epithelium rather than the olfactory 
epithelium (39). Indeed, surgical removal of the respiratory, but 
not olfactory epithelium, eliminated GnRH neurons (40, 41). 
Mouse studies showed that the birth place of GnRH neurons may 
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overlap with a very small portion of the respiratory epithelium that 
borders the olfactory epithelium (34). Overall, these data indicate 
that both the respiratory and olfactory epithelium contribute to the 
OP’s ability to generate GnRH neurons.
Migrating neural crest cells also contribute to the pool of 
GnRH progenitor cells. The bilateral neural crest region arises 
from the edge of the neural plate and shares a border with 
the region that eventually becomes the OP. Indeed, migrating 
neural crest cells contribute to the formation of the OP (42–44). 
As shown in zebrafish experiments, some anterior neural crest 
cells migrate toward the presumptive OP and contribute specific 
cell populations to the developing OP (45). Pre-migratory neu-
ral crest cells labeled with rhodamine dextran in vivo (46, 47) 
also double-labeled for GnRH mRNA and peptide (48). Similar 
data have also been found in mouse studies, which indicate 
that ~30% of the GnRH neurons found in the mOP exhibited 
a genetic lineage similar to neural crest cells (43, 49). The 
remaining 70% of the total population of GnRH neurons were 
confirmed to be of placodal origin. In short, the progenitor cells 
that develop into GnRH neurons are likely to originate from the 
neural crest and the OP.
FiBROBlasT GROwTH FaCTORs anD 
THeiR ReCePTORs
As indicated earlier, FGFs are well-known signaling proteins that 
are crucial for fate specification, migration, differentiation, and 
survival (50). There are 22 members of the FGF signaling family 
found in the mouse (22). Homology between FGFs is based on 
the presence of a highly conserved 120 amino acid core region, 
and the 30–60% overall amino acid identity across all FGFs (22). 
The presence of a N-terminal signal peptide sequence in most 
FGF ligands indicates that they are secreted into the extracellular 
milieu (51).
Fibroblast growth factor signaling is facilitated through 
membrane-bound tyrosine kinase receptors that contain an 
extracellular ligand-binding domain, a transmembrane domain, 
and an intracellular tyrosine kinase domain. In some instances, 
FGFRs translocate to or reside in the cell nucleus (23–26). 
Currently, four FGFRs have been identified in humans and 
mice. The extracellular region of a FGFR is characterized by the 
presence of three immunoglobulin (Ig)-like domains and one 
heparin-binding domain. Stable binding of FGFs in the presence 
of heparin sulfate proteoglycans causes dimerization of FGFRs 
and phosphorylation of cytoplasmic tyrosine residues in the 
kinase domain. This, in turn, initiates a myriad of intracellular 
signal transduction pathways including the phosphorylation of 
SH2 domain of phospholipase Cγ, hydrolysis of phosphatidylino-
sitol bisphosphate to diacylglycerol and inositol trisphosphate, 
resulting in intracellular changes in Ca2+. FGFRs also activate 
the ERK pathway, specifically ERK1 and ERK2 (27). In addition, 
FGF signaling can activate the PI3K/AKT pathway, which in 
turn protects against apoptosis by inhibiting caspases (52, 53). 
The analysis of alternative FGFR mRNA splicing revealed that the 
third Ig-like domain comes in three versions, referred to as IIIa, 
IIIb, or IIIc and are expressed in a tissue-specific manner. Indeed, 
the IIIa form of FGFRs is secreted into extracellular environment, 
whereas the IIIb and IIIc forms of FGFRs are preferentially pre-
sent in epithelial cells and mesenchymal cells, respectively (28). 
Binding affinity studies based on mitogenic activity showed that 
FGFRs can bind a variety of FGF ligands, indicating the presence 
of functional redundancy. For example, signaling of the subfam-
ily of FGF8, 17, and 18 occurs preferentially through FGFR3c < 
FGFR4c < FGFR2c < FGFR1c < < FGFR3b (28). On the other 
hand, recent studies using surface plasmon resonance analysis 
detected  that the binding affinity of the FGF8b splice variant 
(i.e., Kd) to FGFR1≈FGFR2≈FGFR3 indicating that FGF8 sign-
aling may be mediated equally by FGFR1, FGFR2, or FGFR3 (54). 
The complexity and redundancy in FGF ligands and receptors 
demonstrates the inherent robustness of FGF signaling during 
embryonic development.
FGF8 is ReQUiReD FOR GnRH 
neUROn eMeRGenCe
Studies in humans and rodents have confirmed the concept that 
FGF8 signaling is critically important for the emergence of the 
GnRH neuronal system (1, 2, 6, 20, 21). Indeed, GnRH neurons 
are absent in homozygous Fgf8 hypomorphic embryonic and 
newborn mice (2, 6). Not surprisingly, the number of GnRH 
neurons was also reduced in heterozygous Fgf8 hypomorphs 
when compared to wildtype mice (2, 6). Later studies further 
showed that the deficit in GnRH neurons delayed puberty in 
female mice, even though recent studies indicate that FGF8 
dysfunction did not reduce adult male or female hypothalamic 
GnRH peptide synthesis, except on postnatal day 60 (4, 21). 
Together, these results provided a fundamental explanation 
for the reproductive defects found in KS patients who harbor 
hemizygous Fgf8 mutations (55).
The elimination of GnRH neurons likely occurred during 
the emergence phase of GnRH neuronal development (~E9.5–
E10.5). Currently, we do not know whether the elimination of 
the GnRH progenitor cells is due to abrogated FGF8-dependent 
proliferation or cell survival. However, evidence favors the 
second possibility given that the presence of increased apoptosis 
has been reported in the E10.5 OP of mice with reduced Fgf8 
expression (5). Moreover, studies in conditional Fgf8 null mice 
found that apoptosis in the OP was much higher in wildtype 
mice on E10.5. In contrast, no difference was found in the level 
of cell proliferation (56). Therefore, attenuated FGF8 expression 
in the early embryonic OP likely abrogated the survival of GnRH 
(progenitor) cells.
Studies in the chicken embryos confirmed that the timing of 
FGF8 signaling is critical for the emergence of the GnRH in the 
OP (57), which occurs around Hamburger and Hamilton (HH: 
time after egg-laying) 19. HH17 chick OP explant cultures will 
express GnRH mRNA after ~2 days in culture, which the FGFR 
antagonist SU5402 prevented. On the other hand, exogenous 
FGF8 induced and could advance chick GnRH mRNA expression 
(57). These studies confirmed our conclusion that the timing of 
transient FGF8 signaling is critical for the emergence of GnRH 
neurons in the OP (2). Interestingly, exogenous FGF8 had unex-
pected effects on mouse GT1–7 GnRH-secreting neurons. These 
studies showed that treatment with the most abundant FGF8b 
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splice form inhibited GnRH mRNA expression (58). These 
contrasting data sets could indicate that FGF8 affects GnRH 
neuron development in a bi-phasic fashion. First, FGF8 initially 
acts as a neurotrophic factor to prevent the elimination of GnRH 
progenitor cells, thereby allowing the emergence of the GnRH 
neuronal system from the mOP. Second, it has to be recognized 
that FGF8 also functions as morphogenetic factor that maintains 
the proliferative character of progenitor cells (59–63). Therefore, 
continued FGF8 function on GnRH neurons could result in the 
dedifferentiation of fate-specified cells, such as GT1–7 neurons.
Recent cell lineage studies confirmed that Fgf8 mRNA is 
primarily localized in the respiratory epithelium (64). More 
importantly, these studies also indicate that GnRH neurons are 
not derived from Fgf8 expressing respiratory epithelium pro-
genitor cells (11, 32). Therefore, we conclude that Fgf8 expressing 
respiratory epithelial cells may provide trophic support, which 
promotes the survival of E9.5–E10.5 GnRH progenitor cells in 
the mOP (Figure 1).
anDROGen eFFeCTs On TRansienT 
OP Fgf8 TRansCRiPTiOn
Earlier studies indicate that mouse OP Fgf8 mRNA expression 
upregulates around embryonic day (E) 8.5 followed by a down-
regulation around E11.5/12.5 (61, 63, 65, 66). FGF8 was originally 
discovered as an androgen-induced growth factor in SC-3 cells, an 
androgen-dependent mouse breast cancer cell line (67). Studies 
also showed that testosterone induced Fgf8 mRNA in LNCaP 
cells (68). In vitro analysis showed that androgen-bound andro-
gen receptors (ARs) act on androgen response elements (AREs) 
to activate Fgf8 promoter-coupled luciferase activity, which was 
inhibited with the anti-androgens (69). Functional deletion studies 
showed that androgen activates Fgf8 transcription through these 
putative AREs in the Fgf8 promoter (69). Our data confirmed that 
the embryonic mouse OP expresses high AR mRNA levels, while 
ChIP qPCR quantification found that AR interacts with three 
AREs on the mouse Fgf8 promoter in GT1-7 neurons and OP 
explants, in an androgen-independent fashion (70). These results 
led us to conclude that unliganded AR may be responsible for the 
upregulation of OP Fgf8 transcription between E8.5 and E11.5, to 
stimulate GnRH (progenitor) cell emergence/survival. However, 
our recent studies in mouse OP explants showed that androgen 
did not modulate Fgf8 nor did it affect GnRH mRNA expression 
(70) suggesting that androgen, unlike in SC-3 or LNCaP cells, is 
not the primarily regulator of Fgf8 transcription in the embryonic 
mouse OP. However, as discussed later, we cannot fully rule out 
the possibility that androgen signaling effects on Fgf8 expression 
depends on the epigenetic status of the Fgf8 promoter (Figure 1).
ReTinOiC aCiD eFFeCTs On TRansienT 
OP Fgf8 TRansCRiPTiOn
On the other hand, it is clear that all-trans retinoic acid (ATRA) 
signaling is a strong inhibitor of Fgf8 expression in the vertebrate 
OP (Figure 1). For instance, ATRA-soaked beads proximal to the 
chick OP suppresses virtually all nearby Fgf8 expression, which 
was correlated with a coincident elimination of emerging GnRH 
neurons (57). The inhibition of OP Fgf8 expression is thought 
to be caused by local synthesis of ATRA by RA-synthesizing 
aldehyde dehydrogenase 3 (RALDH3) from vitamin A in OP 
cells (Figure 1), which in turn activates retinoid receptors, such 
as RA receptor (RAR) α, β, γ in the developing OP (11, 57, 71). 
RARs bind ATRA and the stereoisomer 9-cis RA, whereas RXRs 
only bind to 9-cis RA (72). Although RARs and RXRs act as 
heterodimeric complexes that affect gene transcription, studies 
indicate that RXRs primarily act as silent partners with respect to 
gene transcription (72–74). Moreover, 9-cis RA is absent in the 
embryonic mouse (72). Data from developmental brain studies 
clearly showed that ATRA acts to spatially and temporally restrict 
Fgf8 mRNA expression to achieve polarity in body axis (75, 76). 
Recently, our preliminary data showed that ATRA prevents 
(unpublished results) the normal upregulation of GnRH expres-
sion found in mouse OP explants (70). Therefore, we conclude 
that ATRA acting through RARs temporally restricts Fgf8 
transcription in the mouse OP region, consequently causing the 
downregulation of OP cell Fgf8 mRNA levels after E11.5/E12.5.
ePiGeneTiC eFFeCTs On TRansienT 
OP Fgf8 TRansCRiPTiOn
As previously mentioned, our recent studies showed that the 
regulation of Fgf8 transcription is under the control of DNA 
methylation, a conclusion that is supported by our recently 
published results (70). Multiple CpG islands upstream and 
downstream of the translation start site of the Fgf8 gene have 
been detected (http://www.ncbi.nlm.nih.gov/geo). The pres-
ence of these CpG islands in the Fgf8 gene suggests that Fgf8 
transcriptional and mRNA expression in OP cells may be DNA 
methylation-dependent. DNA methylation depends on DNMTs, 
which catalyze cytosine methylation in the presence of the 
methyl group donor S-adenosyl methionine (71). Evidence from 
previous studies indicates that E11.5 olfactory progenitor cells 
express high levels of DNMTs (77). Specifically, mitotic olfactory 
progenitors express exclusively DNMT3b, whereas postmitotic 
olfactory neurons express DNMT3a (77). Interestingly, semi-
quantitative analysis showed that Dnmt3b mRNA expression is 
gradually reduced after E11.5 (77). Together with the rise of Fgf8 
transcription between E8.5 and E11.5, we inferred that the Fgf8 
gene may initially be heavily methylated followed by a process 
of DNA demethylation, which is in line with studies indicating 
that DNMT repression in E7.5–E10.5 mice causes global DNA 
demethylation, subsequently upregulating global gene expression 
(78, 79). Therefore, we predicted that reducing DNMT activity 
would induce Fgf8 expression. To investigate this possibility, we 
treated GT1-7 neurons with AZA for 3 days and found that the 
AZA increased Fgf8 mRNA levels (70). These data support that 
erasure of DNA methylation due to reduced DNMT-mediated 
maintenance may induce Fgf8 transcriptional activity (80). 
Currently, we are exploring whether active DNA demethyla-
tion facilitated by ten-eleven translocation enzymes potentiates 
embryonic erasure of DNA methylation in the mouse OP, which 
has not been studied before.
We do not know whether AZA directly controls DNA 
methylation status of the Fgf8 promoter; however, previous 
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studies indicating that hypomethylation in primary rhabdo-
myosarcoma tumors was correlated with higher Fgfr1 mRNA 
expression levels (81). Our current research focuses on verifying 
whether DNA demethylation of the Fgf8 promoter regions is 
the underlying molecular mechanism that causes the upregula-
tion of OP Fgf8 expression, possibly through the inhibition 
of DNMT activity. On the other hand, we cannot rule out 
the possibility that AZA indirectly elicited the upregulation of 
Fgf8 expression, such as inducing or inhibiting the expression 
of AR or RARs.
To our surprise, the non-aromatizable androgen, DHT, elimi-
nated the AZA-dependent rise in Fgf8 mRNA levels, which is the 
basis of our earlier inference that androgen signaling depends 
on the epigenetic status of the Fgf8 promoter region. Based on 
these results, androgen signaling modulation of Fgf8 expression 
may act in concert with other changes in cellular milieu dur-
ing OP development. One possibility is that, in the context of 
epigenetic modification of Fgf8 expression, androgen signaling 
through the AR may act as a transcriptional brake that limits the 
morphogenetic or proliferative effects of FGF8 signaling due to 
DNA demethylation-dependent upregulation of Fgf8 expression. 
For instance, a possibility is that the demethylation of the Fgf8 
promoter allows the constitutively-bound ARs to recruit co-
repressors in the presence of DHT. However, this is highly specu-
lative as there are no data supporting this idea. Nonetheless, these 
results indicate that increased DNA demethylation can induce 
Fgf8 transcription and that androgen signaling is functionally 
repressive.
sUMMaRy anD COnClUsiOn
Our recent research indicates that transient OP Fgf8 transcrip-
tion may be due to the coordinated actions of AR, RARs, and 
DNA demethylation, which together provide a permissive 
transcriptional milieu that initially promotes and later limits 
the emergence of GnRH neurons. Indeed, disruption of transient 
Fgf8 transcription in the OP can eliminate the emergence of the 
entire GnRH neuronal system suggesting that FGF8’s primary 
function is to provide trophic support for the emerging GnRH 
neurons. However, data from GT1-7 neurons indicate that FGF8 
causes a reduction in GnRH mRNA expression. Taken together, 
we conclude that the physiological function of transient Fgf8 
transcription is twofold. Initially, the upregulation of FGF8 pro-
motes and provides trophic support required for the emergence 
of GnRH neurons in the mOP. However, because FGF8 is also 
known to maintain the undifferentiated nature of progenitor 
cells, FGF8 expression in the OP region must be downregulated 
before it dedifferentiates the newly emerged GnRH neurons. 
Based on the presented data, we speculate that the coordinated 
control of transient Fgf8 transcription acts as a molecular system 
that spatially and temporally controls not just the emergence of 
GnRH neurons (i.e., total number) but also whether they remain 
GnRH neurons. In essence, we conclude that transient FGF8 is 
possibly a major molecular cue that controls the number GnRH 
neurons that can emerge from the mOP, which could affect the 
functionality of the GnRH neuronal system as it pertains to the 
HPG-axis and reproductive success.
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